Your browser doesn't support javascript.
loading
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis.
Cortese, Rosa; Battaglini, Marco; Prados, Ferran; Gentile, Giordano; Luchetti, Ludovico; Bianchi, Alessia; Haider, Lukas; Jacob, Anu; Palace, Jacqueline; Messina, Silvia; Paul, Friedemann; Marignier, Romain; Durand-Dubief, Françoise; de Medeiros Rimkus, Carolina; Apostolos Pereira, Samira Luisa; Sato, Douglas Kazutoshi; Filippi, Massimo; Rocca, Maria Assunta; Cacciaguerra, Laura; Rovira, Àlex; Sastre-Garriga, Jaume; Arrambide, Georgina; Liu, Yaou; Duan, Yunyun; Gasperini, Claudio; Tortorella, Carla; Ruggieri, Serena; Amato, Maria Pia; Ulivelli, Monica; Groppa, Sergiu; Grothe, Matthias; Llufriu, Sara; Sepulveda, Maria; Lukas, Carsten; Bellenberg, Barbara; Schneider, Ruth; Sowa, Piotr; Celius, Elisabeth G; Pröbstel, Anne-Katrin; Granziera, Cristina; Yaldizli, Özgür; Müller, Jannis; Stankoff, Bruno; Bodini, Benedetta; Barkhof, Frederik; Ciccarelli, Olga; De Stefano, Nicola.
Affiliation
  • Cortese R; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Battaglini M; Queen Square MS Center, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Prados F; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Gentile G; SIENA imaging SRL, Siena, Italy.
  • Luchetti L; Queen Square MS Center, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Bianchi A; Center for Medical Imaging Computing, Medical Physics, and Biomedical Engineering, UCL, London, UK.
  • Haider L; E-Health Center University Oberta de Catalunya, Barcelona, Spain.
  • Jacob A; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Palace J; SIENA imaging SRL, Siena, Italy.
  • Messina S; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Paul F; SIENA imaging SRL, Siena, Italy.
  • Marignier R; Queen Square MS Center, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Durand-Dubief F; Queen Square MS Center, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • de Medeiros Rimkus C; NMO Clinical Service at the Walton Centre, Liverpool, UK.
  • Apostolos Pereira SL; Department of Neurology, Cleveland Clinic, Abu Dhabi, UAE.
  • Sato DK; Department of Clinical Neurology, John Radcliffe Hospital, Oxford, UK.
  • Filippi M; Department of Clinical Neurology, John Radcliffe Hospital, Oxford, UK.
  • Rocca MA; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité-Universitaetsmedizin Berlin, Berlin, Germany.
  • Cacciaguerra L; Department of Neurology, Multiple Sclerosis, Myelin Disorders, and Neuro-inflammation, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Lyon, France.
  • Rovira À; Department of Neurology, Multiple Sclerosis, Myelin Disorders, and Neuro-inflammation, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Lyon, France.
  • Sastre-Garriga J; Department of Radiology and Oncology, Faculty of Medicine, University of São Paulo (FMUSP), São Paulo, Brazil.
  • Arrambide G; Department of Neurology, Faculty of Medicine, University of São Paulo (FMUSP), São Paulo, Brazil.
  • Liu Y; Pontifical Catholic University of Rio Grande do Sul (PUCRS), School of Medicine, Porto Alegre, Brazil.
  • Duan Y; Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Gasperini C; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Tortorella C; Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Ruggieri S; Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Amato MP; Vita-Salute San Raffaele University, Milan, Italy.
  • Ulivelli M; Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Groppa S; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Grothe M; Vita-Salute San Raffaele University, Milan, Italy.
  • Llufriu S; Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Sepulveda M; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Lukas C; Section of Neuroradiology, Department of Radiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Bellenberg B; Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Schneider R; Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Sowa P; Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Celius EG; Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Pröbstel AK; Department of Neurosciences, S. Camillo-Forlanini Hospital, Rome, Italy.
  • Granziera C; Department of Neurosciences, S. Camillo-Forlanini Hospital, Rome, Italy.
  • Yaldizli Ö; Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
  • Müller J; Neuroimmunology Unit, IRCSS Fondazione Santa Lucia, Rome, Italy.
  • Stankoff B; Department Neurofarba, University of Florence, Florence, Italy.
  • Bodini B; IRCCS Don Carlo Gnocchi Foundation, Florence, Italy.
  • Barkhof F; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Ciccarelli O; Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • De Stefano N; Department of Neurology, University Medicine of Greifswald, Greifswald, Germany.
Ann Neurol ; 96(2): 276-288, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38780377
ABSTRACT

OBJECTIVE:

To evaluate (1) the distribution of gray matter (GM) atrophy in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4+NMOSD), and relapsing-remitting multiple sclerosis (RRMS); and (2) the relationship between GM volumes and white matter lesions in various brain regions within each disease.

METHODS:

A retrospective, multicenter analysis of magnetic resonance imaging data included patients with MOGAD/AQP4+NMOSD/RRMS in non-acute disease stage. Voxel-wise analyses and general linear models were used to evaluate the relevance of regional GM atrophy. For significant results (p < 0.05), volumes of atrophic areas are reported.

RESULTS:

We studied 135 MOGAD patients, 135 AQP4+NMOSD, 175 RRMS, and 144 healthy controls (HC). Compared with HC, MOGAD showed lower GM volumes in the temporal lobes, deep GM, insula, and cingulate cortex (75.79 cm3); AQP4+NMOSD in the occipital cortex (32.83 cm3); and RRMS diffusely in the GM (260.61 cm3). MOGAD showed more pronounced temporal cortex atrophy than RRMS (6.71 cm3), whereas AQP4+NMOSD displayed greater occipital cortex atrophy than RRMS (19.82 cm3). RRMS demonstrated more pronounced deep GM atrophy in comparison with MOGAD (27.90 cm3) and AQP4+NMOSD (47.04 cm3). In MOGAD, higher periventricular and cortical/juxtacortical lesions were linked to reduced temporal cortex, deep GM, and insula volumes. In RRMS, the diffuse GM atrophy was associated with lesions in all locations. AQP4+NMOSD showed no lesion/GM volume correlation.

INTERPRETATION:

GM atrophy is more widespread in RRMS compared with the other two conditions. MOGAD primarily affects the temporal cortex, whereas AQP4+NMOSD mainly involves the occipital cortex. In MOGAD and RRMS, lesion-related tract degeneration is associated with atrophy, but this link is absent in AQP4+NMOSD. ANN NEUROL 2024;96276-288.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrophy / Autoantibodies / Magnetic Resonance Imaging / Neuromyelitis Optica / Aquaporin 4 / Myelin-Oligodendrocyte Glycoprotein / Gray Matter / White Matter Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Neurol Year: 2024 Document type: Article Affiliation country: Italia Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrophy / Autoantibodies / Magnetic Resonance Imaging / Neuromyelitis Optica / Aquaporin 4 / Myelin-Oligodendrocyte Glycoprotein / Gray Matter / White Matter Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Neurol Year: 2024 Document type: Article Affiliation country: Italia Country of publication: Estados Unidos